| Name | Western Drug #3 |
|---|---|
| Organization Name | Texoma Medical Services Inc |
| Location | 202 E Broadway, Vici, Oklahoma 73859 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (580) 995-3500 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Rutgers researchers have linked the genetic disorders Fragile X and SHANK3 deletion syndrome – both linked to autism and health problems – to walking patterns by examining the microscopic movements of those wearing motion-sensored sneakers.
Patients seeking treatment for HIV, malaria, tuberculosis, maternal and child health services missed vital appointments because of the pressures COVID-19 put on Africa's health systems, new research has found.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
RaySearch Laboratories AB has entered into an exclusive distribution agreement with AlphaXRT (formerly CMS Alphatech) based in Sydney, Australia and Auckland, New Zealand. The agreement means that AlphaXRT will be fully responsible for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation in Australia and New Zealand from April 1, 2014.
› Verified 8 days ago
| NPI Number | 1285898544 |
| Organization Name | TEXOMA MEDICAL SERVICES, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 202 E. Broadway, Vici, OK 73859 |
| Phone Number | 580-995-3500 |
News Archive
Rutgers researchers have linked the genetic disorders Fragile X and SHANK3 deletion syndrome – both linked to autism and health problems – to walking patterns by examining the microscopic movements of those wearing motion-sensored sneakers.
Patients seeking treatment for HIV, malaria, tuberculosis, maternal and child health services missed vital appointments because of the pressures COVID-19 put on Africa's health systems, new research has found.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
RaySearch Laboratories AB has entered into an exclusive distribution agreement with AlphaXRT (formerly CMS Alphatech) based in Sydney, Australia and Auckland, New Zealand. The agreement means that AlphaXRT will be fully responsible for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation in Australia and New Zealand from April 1, 2014.
› Verified 8 days ago
| NPI Number | 1639133432 |
| Organization Name | TEXOMA MEDICAL SERVICES INC |
| Doing Business As | WESTERN DRUG #3 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 202 E. Broadway, Vici, OK 73859 |
| Phone Number | 580-995-3500 |
News Archive
Rutgers researchers have linked the genetic disorders Fragile X and SHANK3 deletion syndrome – both linked to autism and health problems – to walking patterns by examining the microscopic movements of those wearing motion-sensored sneakers.
Patients seeking treatment for HIV, malaria, tuberculosis, maternal and child health services missed vital appointments because of the pressures COVID-19 put on Africa's health systems, new research has found.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
RaySearch Laboratories AB has entered into an exclusive distribution agreement with AlphaXRT (formerly CMS Alphatech) based in Sydney, Australia and Auckland, New Zealand. The agreement means that AlphaXRT will be fully responsible for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation in Australia and New Zealand from April 1, 2014.
› Verified 8 days ago
News Archive
Rutgers researchers have linked the genetic disorders Fragile X and SHANK3 deletion syndrome – both linked to autism and health problems – to walking patterns by examining the microscopic movements of those wearing motion-sensored sneakers.
Patients seeking treatment for HIV, malaria, tuberculosis, maternal and child health services missed vital appointments because of the pressures COVID-19 put on Africa's health systems, new research has found.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
RaySearch Laboratories AB has entered into an exclusive distribution agreement with AlphaXRT (formerly CMS Alphatech) based in Sydney, Australia and Auckland, New Zealand. The agreement means that AlphaXRT will be fully responsible for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation in Australia and New Zealand from April 1, 2014.
› Verified 8 days ago
Western Drug #3 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 202 E Broadway, Vici, Oklahoma 73859 Phone: (580) 995-3500 |